Ras, PI(3)K and mTOR signalling controls tumour cell growth
- PMID: 16724053
- DOI: 10.1038/nature04869
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Abstract
All eukaryotic cells coordinate cell growth with the availability of nutrients in their environment. The mTOR protein kinase has emerged as a critical growth-control node, receiving stimulatory signals from Ras and phosphatidylinositol-3-OH kinase (PI(3)K) downstream from growth factors, as well as nutrient inputs in the form of amino-acid, glucose and oxygen availability. Notably, components of the Ras and PI(3)K signalling pathways are mutated in most human cancers. The preponderance of mutations in these interconnected pathways suggests that the loss of growth-control checkpoints and promotion of cell survival in nutrient-limited conditions may be an obligate event in tumorigenesis.
Similar articles
-
[Targeting Ras-PI3K/mTOR pathway and the predictive biomarkers in endometrial cancer].Gan To Kagaku Ryoho. 2011 Jul;38(7):1084-7. Gan To Kagaku Ryoho. 2011. PMID: 21772091 Japanese.
-
Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism.Biochem J. 2004 Jun 15;380(Pt 3):795-804. doi: 10.1042/BJ20040274. Biochem J. 2004. PMID: 15030312 Free PMC article.
-
EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.BMC Cell Biol. 2006 Sep 19;7:34. doi: 10.1186/1471-2121-7-34. BMC Cell Biol. 2006. PMID: 16984645 Free PMC article.
-
[Advances on PI3K/Akt/mTOR signalling pathway in malignancies].Zhonghua Bing Li Xue Za Zhi. 2005 Oct;34(10):674-6. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16536284 Review. Chinese. No abstract available.
-
Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis.Cell Cycle. 2007 Dec 1;6(23):2902-5. doi: 10.4161/cc.6.23.4996. Epub 2007 Aug 31. Cell Cycle. 2007. PMID: 17993782 Review.
Cited by
-
The mTOR pathway in hepatic malignancies.Hepatology. 2013 Aug;58(2):810-8. doi: 10.1002/hep.26323. Epub 2013 Apr 17. Hepatology. 2013. PMID: 23408390 Free PMC article. Review.
-
AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.Proc Natl Acad Sci U S A. 2021 May 18;118(20):e2026104118. doi: 10.1073/pnas.2026104118. Proc Natl Acad Sci U S A. 2021. PMID: 33972443 Free PMC article.
-
Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.Cancer Res. 2013 Jun 1;73(11):3393-401. doi: 10.1158/0008-5472.CAN-12-4282. Epub 2013 Apr 30. Cancer Res. 2013. PMID: 23633493 Free PMC article.
-
Evolving role of adiponectin in cancer-controversies and update.Cancer Biol Med. 2016 Mar;13(1):101-19. doi: 10.28092/j.issn.2095-3941.2015.0092. Cancer Biol Med. 2016. PMID: 27144066 Free PMC article.
-
Intrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and Function.Front Immunol. 2016 Mar 29;7:114. doi: 10.3389/fimmu.2016.00114. eCollection 2016. Front Immunol. 2016. PMID: 27066006 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous